Merck presented Professor David Alsteens (33), Catholic University of Louvain (UCLovain), Louvain-la-Neuve, Belgium with the 2019 Heinrich Emanuel Merck Award for Analytical Science. The award ceremony took place during the analytical conference Euroanalysis at Istanbul University in Turkey ... more
Merck Acquires laboratory informatics company
Merck has acquired BSSN Software, a Darmstadt, Germany-based laboratory informatics company that makes data more readily accessible for ease of integration, collaboration, analysis and long-term archiving. Financial details were not disclosed.
“BSSN Software and the capabilities that it brings will allow Merck’s customers to better use and share their scientific data — the most important part of laboratory experiments,” said Jean-Charles Wirth, head of Applied Solutions at the Life Science business sector of Merck. “We acquired this company for commercial growth of the lab data management technology that BSSN provided for many years. This acquisition creates opportunity and gives Merck a unique position in this fast-paced market.”
BSSN Software is known for developing and marketing data management and integration software that unifies data from instruments and data systems and makes them available for analyzing, processing and sharing. It collects and converts scientific data from a broad range of more than 200 lab instrument models into a single, unified format. As a middleware offering, it facilitates communication and data flow between instruments and systems, such as laboratory information management systems, electronic lab notebooks and enterprise resource planning systems. The acquisition complements Merck’s efforts to support its customers’ digital transformation in the lab.
Since 2014, Merck has been working with BSSN Software, which primarily served pharmaceutical and food and beverage customers and provided services to facilitate standard laboratory efforts. BSSN Software was the first company to introduce to the market a complete AnIML implementation, an open standardized XML data format for storing and sharing of experiment data. With this acquisition, Merck is combining BSSN’s technology with its market access and laboratory domain knowledge to develop and commercialize an open and interoperable platform for laboratory data.
Merck is committed to the continued development and support of the current BSSN Software product portfolio, its customers and partnerships, as well as an open ecosystem building on the AnIML standard and Standardization in Lab Automation.
BSSN’s employees have joined Merck as part of its Applied Digital Lab Productivity Solutions team.
- laboratory informat…
- laboratory software
Merck and Rigaku Corp., Tokyo, Japan, have signed a joint development agreement to develop lab consumables based on crystalline sponge technology, which determines the absolute chemical structure of organic molecules and enables X-ray crystallography without crystallization of the analyte. ... more
Merck generated very strong organic sales growth in the third quarter of 2018. However, this was impacted by negative exchange rate effects. Despite organic growth, EBITDA pre of the Group also declined in comparison with the year-earlier quarter owing to strong negative foreign exchange ef ... more
See how premium quality, unique packaging, and new 2D data matrix labels make EMSURE® inorganics and solvents the smartest choice for precise analysis. more
Buffers are an essential part of laboratory experiments. The pHast Pack™ ready-to-use buffers are specially designed to simplify your work. Simply mix the precisely pre-weighed packets with distilled water for quick results that are reliably reproducible again and again. By saving time, eff ... more
- 1Virtual screening for active substances against the coronavirus
- 2analytica 2020 is postponed
- 3Thermo Fisher Scientific to Acquire QIAGEN
- 4FDA Provides Emergency Use Authorization to PerkinElmer for COVID-19 Testing
- 5The digital laboratory live and tangible
- 6Roche’s cobas SARS-CoV-2 Test to detect novel coronavirus receives FDA Emergency Use Authorization
- 7Smartphone lab finds coronavirus in saliva
- 8Abbott Receives FDA Emergency Use Authorization and Launches Test to Detect Novel Coronavirus
- 9Pool testing of SARS-CoV-02 samples increases worldwide test capacities many times over
- 10New membrane separates small organic molecules
- Corona research at BESSY II: Two days of measuring operation to find the right key
- Ultra-fast switching of helicity of circularly polarized light pulses
- Lifting the lid on beta-barrels
- Pool testing of SARS-CoV-02 samples increases worldwide test capacities many times over
- Bosch develops rapid test for COVID-19